Loading...
Header Logo
Keywords
Last Name
Institution

Udho Thadani

TitleProf Emeritus
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentMedicine Cardiology
Phone405/271-4742
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Thadani U. Trimetazidine for stable and unstable ischemic heart diseases and for heart failure: Is its routine use justified from available data? Int J Cardiol. 2019 Aug 01. PMID: 31402158.
      View in: PubMed
    2. Rousan TA, Thadani U. Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence. Eur Cardiol. 2019 Apr; 14(1):18-22. PMID: 31131033.
      View in: PubMed
    3. Shah B, Thadani U. Trans fatty acids linked to myocardial infarction and stroke: What is the evidence? Trends Cardiovasc Med. 2019 07; 29(5):306-310. PMID: 31130187.
      View in: PubMed
    4. Thadani U. Editorial commentary: Treatment of refractory angina: An ongoing challenge. Trends Cardiovasc Med. 2018 04; 28(3):229-230. PMID: 29273184.
      View in: PubMed
    5. Rousan TA, Thadani U. Stent choice in cardiogenic shock complicating acute myocardial infarction likely does not affect mortality or reinfarction. Evid Based Med. 2017 12; 22(6):224. PMID: 29102922.
      View in: PubMed
    6. Mathew ST, Po SS, Thadani U. Inappropriate sinus tachycardia-symptom and heart rate reduction with ivabradine: A pooled analysis of prospective studies. Heart Rhythm. 2018 02; 15(2):240-247. PMID: 29017929.
      View in: PubMed
    7. Thadani U. Routine invasive strategies compared with conservative strategies do not lower the all-cause mortality in patients with non-ST elevation myocardial infarction and unstable angina. Evid Based Med. 2017 10; 22(5):190. PMID: 28775170.
      View in: PubMed
    8. Rousan TA, Mathew ST, Thadani U. Drug Therapy for Stable Angina Pectoris. Drugs. 2017 Mar; 77(3):265-284. PMID: 28120185.
      View in: PubMed
    9. Rousan TA, Mathew ST, Thadani U. The risk of cardiovascular side effects with anti-anginal drugs. Expert Opin Drug Saf. 2016 Dec; 15(12):1609-1623. PMID: 27659354.
      View in: PubMed
    10. Thadani U. Management of Stable Angina - Current Guidelines: A Critical Appraisal. Cardiovasc Drugs Ther. 2016 Aug; 30(4):419-426. PMID: 27638354.
      View in: PubMed
    11. Mathew ST, Pakala AV, Thadani U. Invasive strategy in acute coronary syndrome. Lancet. 2016 Jun 18; 387(10037):2503-4. PMID: 27353678.
      View in: PubMed
    12. Patel N, Ju C, Macon C, Thadani U, Schulte PJ, Hernandez AF, Bhatt DL, Butler J, Yancy CW, Fonarow GC. Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry. JACC Heart Fail. 2016 05; 4(5):348-56. PMID: 26874392.
      View in: PubMed
    13. Patel N, Patel NJ, Thakkar B, Singh V, Arora S, Patel N, Savani C, Deshmukh A, Thadani U, Badheka AO, Alfonso C, Fonarow GC, Cohen MG. Management Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United States. Clin Cardiol. 2016 Jan; 39(1):9-18. PMID: 26785349.
      View in: PubMed
    14. Thadani U, Latif F. Percutaneous coronary interventions in the elderly improve quality of life: evidence far from certain. Cardiology. 2014; 129(1):44-5. PMID: 25096401.
      View in: PubMed
    15. Thadani U. Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance. Am J Cardiovasc Drugs. 2014 Aug; 14(4):287-301. PMID: 24664980.
      View in: PubMed
    16. Thadani U, Latif F. Pigment epithelial-derived factor and acute coronary syndrome: a novel protective biomarker but not for routine clinical use at present. Cardiology. 2014; 127(1):28-30. PMID: 24192803.
      View in: PubMed
    17. Golwala HB, Thadani U, Liang L, Stavrakis S, Butler J, Yancy CW, Bhatt DL, Hernandez AF, Fonarow GC. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Aug 21; 2(4):e000214. PMID: 23966379.
      View in: PubMed
    18. McCullough PA, Barnard D, Clare R, Ellis SJ, Fleg JL, Fonarow GC, Franklin BA, Kilpatrick RD, Kitzman DW, O'Connor CM, Piña IL, Thadani U, Thohan V, Whellan DJ. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function. Clin Cardiol. 2013 Oct; 36(10):611-20. PMID: 23929781.
      View in: PubMed
    19. Thadani U, Latif F. Retroperitoneal hemorrhage after cardiac catheterization and percutaneous coronary interventions. Cardiology. 2013; 126(1):24-6. PMID: 23860184.
      View in: PubMed
    20. Dasari TW, Golwala H, Koehler M, Wayangankar S, Pakala A, Schechter E, Lozano P, Abu-Fadel MS, Latif F, Thadani U. Is risk factor control and guideline-based medical therapy optimal in patients with nonobstructive coronary artery disease? A Veterans Affairs study. Am J Med Sci. 2013 May; 345(5):339-42. PMID: 23044654.
      View in: PubMed
    21. Stavrakis S, Pakala A, Thomas J, Chaudhry MA, Thadani U. Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function. Am J Med Sci. 2013 Mar; 345(3):211-7. PMID: 23422653.
      View in: PubMed
    22. Thadani U. Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal. Expert Opin Pharmacother. 2012 Dec; 13(17):2555-63. PMID: 23121448.
      View in: PubMed
    23. Thadani U. Osteoprotegerin and ST segment myocardial infarction: a novel risk marker but not for routine use at present. Cardiology. 2012; 123(2):91-3. PMID: 23018624.
      View in: PubMed
    24. Boden WE, Finn AV, Patel D, Peacock WF, Thadani U, Zimmerman FH. Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics. Clin Cardiol. 2012 May; 35(5):263-71. PMID: 22528319.
      View in: PubMed
    25. Thadani U, Wittig T. A randomized, double-blind, placebo-controlled, crossover, dose-ranging multicenter study to determine the effect of sublingual nitroglycerin spray on exercise capacity in patients with chronic stable angina. Clin Med Insights Cardiol. 2012; 6:87-95. PMID: 22566749.
      View in: PubMed
    26. Piller LB, Baraniuk S, Simpson LM, Cushman WC, Massie BM, Einhorn PT, Oparil S, Ford CE, Graumlich JF, Dart RA, Parish DC, Retta TM, Cuyjet AB, Jafri SZ, Furberg CD, Saklayen MG, Thadani U, Probstfield JL, Davis BR. Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Circulation. 2011 Oct 25; 124(17):1811-8. PMID: 21969009.
      View in: PubMed
    27. Stavrakis S, Lazzara R, Thadani U. The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis. J Cardiovasc Electrophysiol. 2012 Feb; 23(2):163-8. PMID: 21815961.
      View in: PubMed
    28. Gardner AW, Montgomery PS, Ritti-Dias RM, Thadani U. Exercise performance, physical activity, and health-related quality of life in participants with stable angina. Angiology. 2011 Aug; 62(6):461-6. PMID: 21421630.
      View in: PubMed
    29. Stavrakis S, Stoner JA, Azar M, Wayangankar S, Thadani U. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis. Am J Med Sci. 2011 Jan; 341(1):1-9. PMID: 21191260.
      View in: PubMed
    30. Keteyian SJ, Isaac D, Thadani U, Roy BA, Bensimhon DR, McKelvie R, Russell SD, Hellkamp AS, Kraus WE. Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J. 2009 Oct; 158(4 Suppl):S72-7. PMID: 19782792.
      View in: PubMed
    31. Patel JH, Stoner JA, Owora A, Mathew ST, Thadani U. Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients. Am J Cardiol. 2009 Jun 15; 103(12):1687-93. PMID: 19539077.
      View in: PubMed
    32. Thadani U. Treatment with statins in high-risk patients: relevance of time to titration of dose and adverse outcomes. Am J Cardiovasc Drugs. 2009; 9(3):211-2; author reply 212. PMID: 19463025.
      View in: PubMed
    33. Thadani U, Jacob RG. Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure. Drugs Today (Barc). 2008 Dec; 44(12):925-37. PMID: 19198701.
      View in: PubMed
    34. Black HR, Davis B, Barzilay J, Nwachuku C, Baimbridge C, Marginean H, Wright JT, Basile J, Wong ND, Whelton P, Dart RA, Thadani U. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2008 Feb; 31(2):353-60. PMID: 18000186.
      View in: PubMed
    35. Thadani U, Ripley TL. Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarction. Expert Opin Drug Saf. 2007 Jul; 6(4):385-96. PMID: 17688382.
      View in: PubMed
    36. Thadani U, Rodgers T. Side effects of using nitrates to treat angina. Expert Opin Drug Saf. 2006 Sep; 5(5):667-74. PMID: 16907656.
      View in: PubMed
    37. Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, Alderman MH, Atlas SA, Basile JN, Cuyjet AB, Dart R, Felicetta JV, Grimm RH, Haywood LJ, Jafri SZ, Proschan MA, Thadani U, Whelton PK, Wright JT. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006 Sep; 48(3):374-84. PMID: 16864749.
      View in: PubMed
    38. Thadani U. Selection of optimal therapy for chronic stable angina. Curr Treat Options Cardiovasc Med. 2006 Feb; 8(1):23-35. PMID: 16401381.
      View in: PubMed
    39. Vicari RM, Chaitman B, Keefe D, Smith WB, Chrysant SG, Tonkon MJ, Bittar N, Weiss RJ, Morales-Ballejo H, Thadani U. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol. 2005 Nov 15; 46(10):1803-11. PMID: 16286163.
      View in: PubMed
    40. Abrams J, Thadani U. Therapy of stable angina pectoris: the uncomplicated patient. Circulation. 2005 Oct 11; 112(15):e255-9. PMID: 16216965.
      View in: PubMed
    41. Whelton PK, Barzilay J, Cushman WC, Davis BR, Iiamathi E, Kostis JB, Leenen FH, Louis GT, Margolis KL, Mathis DE, Moloo J, Nwachuku C, Panebianco D, Parish DC, Pressel S, Simmons DL, Thadani U. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005 Jun 27; 165(12):1401-9. PMID: 15983290.
      View in: PubMed
    42. Thadani U. Can nicorandil treat angina pectoris effectively? Nat Clin Pract Cardiovasc Med. 2005 Apr; 2(4):186-7. PMID: 16265479.
      View in: PubMed
    43. Thadani U. Modified-release formulation of trimetazidine for exceptional control of angina pectoris: fact or fiction. Am J Cardiovasc Drugs. 2005; 5(5):331-4. PMID: 16156689.
      View in: PubMed
    44. Thadani U. Current medical management of chronic stable angina. J Cardiovasc Pharmacol Ther. 2004 Sep; 9 Suppl 1:S11-29; quiz S98-9. PMID: 15378129.
      View in: PubMed
    45. Thadani U. Prevention of nitrate tolerance with angiotensin II receptor type 1 blocker in patients with stable angina: yet another failed strategy to prevent tolerance. Cardiovasc Drugs Ther. 2004 Sep; 18(5):339-42. PMID: 15717134.
      View in: PubMed
    46. Thadani U. Recurrent and refractory angina following revascularization procedures in patients with stable angina pectoris. Coron Artery Dis. 2004 May; 15 Suppl 1:S1-4. PMID: 15179121.
      View in: PubMed
    47. Pepine CJ, Rouleau JL, Annis K, Ducharme A, Ma P, Lenis J, Davies R, Thadani U, Chaitman B, Haber HE, Freedman SB, Pressler ML, Pitt B. Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial. J Am Coll Cardiol. 2003 Dec 17; 42(12):2049-59. PMID: 14680725.
      View in: PubMed
    48. Fox KM, Thadani U, Ma PT, Nash SD, Keating Z, Czorniak MA, Gillies H, Keltai M. Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. Eur Heart J. 2003 Dec; 24(24):2206-12. PMID: 14659772.
      View in: PubMed
    49. Pepine CJ, Cooper-DeHoff RM, Weiss RJ, Koren M, Bittar N, Thadani U, Minkwitz MC, Michelson EL, Hutchinson HG. Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. Am J Cardiol. 2003 Feb 01; 91(3):274-9. PMID: 12565082.
      View in: PubMed
    50. Thadani U, Smith W, Nash S, Bittar N, Glasser S, Narayan P, Stein RA, Larkin S, Mazzu A, Tota R, Pomerantz K, Sundaresan P. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J Am Coll Cardiol. 2002 Dec 04; 40(11):2006-12. PMID: 12475462.
      View in: PubMed
    51. Thadani U. Selective L-type, T-type, and nonspecific calcium-channel blockers for stable angina pectoris. Am Heart J. 2002 Jul; 144(1):8-10. PMID: 12094182.
      View in: PubMed
    52. Philbin EF, Hunsberger S, Garg R, Lader E, Thadani U, McSherry F, Silver MA. Usefulness of clinical information to distinguish patients with normal from those with low ejection fractions in heart failure. Am J Cardiol. 2002 May 15; 89(10):1218-21. PMID: 12008182.
      View in: PubMed
    53. Kostis JB, Dockens RC, Thadani U, Bethala V, Pepine C, Leimbach W, Vachharajani N, Raymond RH, Stouffer BC, Tay LK, Shyu WC, Liao WC. Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarction. Clin Pharmacokinet. 2002; 41(6):445-52. PMID: 12074692.
      View in: PubMed
    54. Hamilton SF, Houle LM, Thadani U. Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure. Heart Dis. 1999 Nov-Dec; 1(5):279-88. PMID: 11720635.
      View in: PubMed
    55. Thadani U. Treatment of stable angina. Curr Opin Cardiol. 1999 Jul; 14(4):349-58. PMID: 10448616.
      View in: PubMed
    56. den Heijer P, Vermeer F, Ambrosioni E, Sadowski Z, López-Sendón JL, von Essen R, Beaufils P, Thadani U, Adgey J, Pierard L, Brinker J, Davies RF, Smalling RW, Wallentin L, Caspi A, Pangerl A, Trickett L, Hauck C, Henry D, Chew P. Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase. Circulation. 1998 Nov 17; 98(20):2117-25. PMID: 9815865.
      View in: PubMed
    57. Ma L, Yu Z, Xiao S, Thadani U, Robinson CP, Patterson E. Supersensitivity to serotonin- and histamine-induced arterial contraction following ovariectomy. Eur J Pharmacol. 1998 Oct 23; 359(2-3):191-200. PMID: 9832391.
      View in: PubMed
    58. Asirvatham S, Sebastian C, Thadani U. Choosing the most appropriate treatment for stable angina. Safety considerations. Drug Saf. 1998 Jul; 19(1):23-44. PMID: 9673856.
      View in: PubMed
    59. Thadani U, Roden DM. FDA Panel report: January 1998. Circulation. 1998 Jun 16; 97(23):2295-6. PMID: 9639370.
      View in: PubMed
    60. Asirvatham S, Sebastian C, Thadani U. Severe symptomatic sinus bradycardia associated with mesalamine use. Am J Gastroenterol. 1998 Mar; 93(3):470-1. PMID: 9517663.
      View in: PubMed
    61. Patterson E, Ma L, Szabo B, Robinson CP, Thadani U. Ovariectomy and estrogen-induced alterations in myocardial contractility in female rabbits: role of the L-type calcium channel. J Pharmacol Exp Ther. 1998 Feb; 284(2):586-91. PMID: 9454801.
      View in: PubMed
    62. Deedwania PC, Pool PE, Thadani U, Eff J. Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group. Am J Cardiol. 1997 Aug 15; 80(4):421-5. PMID: 9285652.
      View in: PubMed
    63. Kamalesh M, Chandrasekaran K, Sivaram CA, Thadani U. Lack of arrhythmogenicity with ST-segment elevation during high-dose of dobutamine atropine stress in patients with documented or suspected coronary artery disease. Am J Cardiol. 1997 Aug 01; 80(3):341-3. PMID: 9264431.
      View in: PubMed
    64. Ma L, Robinson CP, Thadani U, Patterson E. Effect of 17-beta estradiol in the rabbit: endothelium-dependent and -independent mechanisms of vascular relaxation. J Cardiovasc Pharmacol. 1997 Jul; 30(1):130-5. PMID: 9268232.
      View in: PubMed
    65. Thadani U. Management of patients with chronic stable angina at low risk for serious cardiac events. Am J Cardiol. 1997 Jun 26; 79(12B):24-30. PMID: 9223354.
      View in: PubMed
    66. Glasser SP, Michie DD, Thadani U, Baiker WM. Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators. Am J Cardiol. 1997 May 15; 79(10):1401-5. PMID: 9165168.
      View in: PubMed
    67. Thadani U. Oral nitrates: more than symptomatic therapy in coronary artery disease? Cardiovasc Drugs Ther. 1997 May; 11 Suppl 1:213-8. PMID: 9211013.
      View in: PubMed
    68. Alpert JS, Kobrin I, DeQuattro V, Friedman R, Shepherd A, Fenster PE, Thadani U. Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris. Am J Cardiol. 1997 Apr 15; 79(8):1025-30. PMID: 9114758.
      View in: PubMed
    69. Thadani U. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure. Cardiovasc Drugs Ther. 1997 Jan; 10(6):735-42. PMID: 9110117.
      View in: PubMed
    70. Thadani U. Secondary preventive potential of nitrates in ischaemic heart disease. Eur Heart J. 1996 Dec; 17 Suppl F:30-6. PMID: 8960445.
      View in: PubMed
    71. Ma L, Hsu CH, Patterson E, Thadani U, Robinson CP. Ricin depresses cardiac function in the rabbit heart. Toxicol Appl Pharmacol. 1996 May; 138(1):72-6. PMID: 8658515.
      View in: PubMed
    72. Ma L, Hsu CH, Fugate R, Patterson E, Thadani U, Robinson CP. Ricin disturbs calcium homeostasis in the rabbit heart. J Biochem Toxicol. 1995 Dec; 10(6):323-8. PMID: 8934635.
      View in: PubMed
    73. Thadani U, Chohan A. Chronic stable angina pectoris. Strategies for effective drug therapy. Postgrad Med. 1995 Dec; 98(6):175-6, 179-83, 187-8. PMID: 7501578.
      View in: PubMed
    74. Thadani U, Chohan A. Chronic stable angina pectoris. Postgrad Med. 1995 Dec; 98(6):175-188. PMID: 29224440.
      View in: PubMed
    75. Ezekowitz MD, Hossack K, Mehta JL, Thadani U, Weidler DJ, Kostuk W, Awan N, Grossman W, Bommer W. Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial. Am Heart J. 1995 Mar; 129(3):527-35. PMID: 7872184.
      View in: PubMed
    76. Thadani U, Opie LH. Nitrates for unstable angina. Cardiovasc Drugs Ther. 1994 Oct; 8(5):719-26. PMID: 7873468.
      View in: PubMed
    77. Pool PE, Thadani U, Miller AB, Fromell GJ, Eff J. Conversion from immediate-release to extended-release diltiazem in angina pectoris. Clin Cardiol. 1994 Sep; 17(9):484-8. PMID: 8001312.
      View in: PubMed
    78. Thadani U, Lipicky RJ. Short and long-acting oral nitrates for stable angina pectoris. Cardiovasc Drugs Ther. 1994 Aug; 8(4):611-23. PMID: 7848896.
      View in: PubMed
    79. Thadani U, Lipicky RJ. Ointments and transdermal nitroglycerin patches for stable angina pectoris. Cardiovasc Drugs Ther. 1994 Aug; 8(4):625-33. PMID: 7848897.
      View in: PubMed
    80. Thadani U, Ezekowitz M, Fenney L, Chiang YK. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group. Circulation. 1994 Aug; 90(2):726-34. PMID: 8044941.
      View in: PubMed
    81. Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, Miller E, Marks RG, Thadani U. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) Circulation. 1994 Aug; 90(2):762-8. PMID: 8044945.
      View in: PubMed
    82. Thadani U, Glasser S, Bittar N, Beach CL. Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group. Am J Cardiol. 1994 Jul 01; 74(1):9-17. PMID: 8017316.
      View in: PubMed
    83. Thadani U, Chrysant S, Gorwit J, Giles T, Archer S, Iteld B, Singh S, Copen D, Wakeford C, Hobbs S. Duration of effects of isradipine during twice daily therapy in angina pectoris. Cardiovasc Drugs Ther. 1994 Apr; 8(2):199-210. PMID: 7918132.
      View in: PubMed
    84. Thadani U, Maranda CR, Amsterdam E, Spaccavento L, Friedman RG, Chernoff R, Zellner S, Gorwit J, Hinderaker PH. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate. Ann Intern Med. 1994 Mar 01; 120(5):353-9. PMID: 8093132.
      View in: PubMed
    85. Frishman WH, Amsterdam E, Glasser SP, Thadani U. Mononitrates: defining the ideal long-acting nitrate. Clin Ther. 1994 Mar-Apr; 16(2):130-9; discussion 129. PMID: 7914830.
      View in: PubMed
    86. Thadani U. Nitrate therapy and the development of tolerance. Arch Fam Med. 1993 Aug; 2(8):880-5. PMID: 8141915.
      View in: PubMed
    87. Kalbfleisch JM, Kurnik PB, Thadani U, DeWood MA, Kent R, Magorien RD, Jain AC, Spaccavento LJ, Morris DL, Taylor GJ, et al. Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wellcome Study Group. Am J Cardiol. 1993 Feb 15; 71(5):386-92. PMID: 8430624.
      View in: PubMed
    88. Thadani U, de Vane PJ. Efficacy of isosorbide mononitrate in angina pectoris. Am J Cardiol. 1992 Nov 27; 70(17):67G-71G. PMID: 1449103.
      View in: PubMed
    89. Thadani U. Role of nitrates in angina pectoris. Am J Cardiol. 1992 Sep 24; 70(8):43B-53B. PMID: 1529926.
      View in: PubMed
    90. Thadani U, Bittar N. Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris. Am J Cardiol. 1992 Aug 01; 70(3):286-92. PMID: 1632390.
      View in: PubMed
    91. Kalbfleisch J, Thadani U, LittleJohn JK, Brown G, Magorien R, Kutcher M, Taylor G, Maddox WT, Campbell WB, Perry J, et al. Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction. Am J Cardiol. 1992 May 01; 69(14):1120-7. PMID: 1575179.
      View in: PubMed
    92. Thadani U. Nitrate tolerance. How to prevent it or minimize its effect. Postgrad Med. 1992 Apr; 91(5):307-12, 315-8. PMID: 1561169.
      View in: PubMed
    93. Thadani U, Zellner SR, Glasser S, Bittar N, Montoro R, Miller AB, Chaitman B, Schulman P, Stahl A, DiBianco R, et al. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. Circulation. 1991 Dec; 84(6):2398-408. PMID: 1959195.
      View in: PubMed
    94. Thadani U, Whitsett TL. Beta-adrenergic blockers and intermittent claudication. Time for reappraisal. Arch Intern Med. 1991 Sep; 151(9):1705-7. PMID: 1679623.
      View in: PubMed
    95. Thadani U. Medical therapy of stable angina pectoris. Cardiol Clin. 1991 Feb; 9(1):73-87. PMID: 1674227.
      View in: PubMed
    96. Swartz SL, Gonasun LM, McAllister RG, Thadani U. A multicenter comparison of isradipine and prazosin for treatment of essential hypertension. Cardiovasc Drugs Ther. 1990 Apr; 4(2):413-7. PMID: 2149512.
      View in: PubMed
    97. Thadani U. Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group. Am Heart J. 1989 Nov; 118(5 Pt 2):1135. PMID: 2530876.
      View in: PubMed
    98. Thadani U, Whitsett T, Hamilton SF. Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance. Curr Probl Cardiol. 1988 Nov; 13(11):723-84. PMID: 3069336.
      View in: PubMed
    99. Sung BH, Wilson MF, Robinson C, Thadani U, Lovallo WR. Mechanisms of myocardial ischemia induced by epinephrine: comparison with exercise-induced ischemia. Psychosom Med. 1988 Jul-Aug; 50(4):381-93. PMID: 3413271.
      View in: PubMed
    100. Thadani U, Whitsett T. Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates. Clin Pharmacokinet. 1988 Jul; 15(1):32-43. PMID: 3135973.
      View in: PubMed
    101. Sharma MK, Voyles W, Prasad R, Teague SM, Thadani U. Long-term bepridil monotherapy for angina pectoris. Am J Cardiol. 1988 Jun 01; 61(15):1210-3. PMID: 3287882.
      View in: PubMed
    102. Sung BH, Robinson C, Thadani U, Lee R, Wilson MF. Effects of 1-epinephrine on hemodynamics and cardiac function in coronary disease: dose-response studies. Clin Pharmacol Ther. 1988 Mar; 43(3):308-16. PMID: 3345621.
      View in: PubMed
    103. Goli VD, Teague SM, Prasad R, Harvey J, Voyles WF, Olson EG, Schechter E, Thadani U. Noninvasive evaluation of aortic stenosis severity utilizing Doppler ultrasound and electrical bioimpedance. J Am Coll Cardiol. 1988 Jan; 11(1):66-71. PMID: 3335708.
      View in: PubMed
    104. Thadani U. Amlodipine--a once-daily calcium antagonist in the treatment of angina pectoris: a parallel dose-response placebo-controlled study. J Cardiovasc Pharmacol. 1988; 12 Suppl 7:S114. PMID: 2467120.
      View in: PubMed
    105. Thadani U, Prasad R, Hamilton SF, Voyles W, Doyle R, Karpow S, Reder R, Teague SM. Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris. Am J Cardiol. 1987 Sep 01; 60(7):477-82. PMID: 3630929.
      View in: PubMed
    106. Thadani U, Whitsett TL. Nitrate therapy: continuous or pulse dosing. Ration Drug Ther. 1987 Jul; 21(7):1-6. PMID: 3124208.
      View in: PubMed
    107. Thadani U, Prasad R, Hamilton SF, Voyles WF, Doyle R, Karpow SA, Reder R, Teague SM. Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy. Clin Pharmacol Ther. 1987 Jul; 42(1):58-65. PMID: 3595067.
      View in: PubMed
    108. Thadani U, Hamilton SF, Olson E, Anderson JL, Prasad R, Voyles W, Doyle R, Kirsten E, Teague SM. Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris. Am J Cardiol. 1987 Apr 01; 59(8):756-62. PMID: 3825935.
      View in: PubMed
    109. Fenster PE, Reynolds D, Horwitz LD, Morrison D, Goldman S, Thadani U, Lazzara R, Serokman R, Marcus FI. Atenolol for ventricular ectopy: a dose-response study. Clin Pharmacol Ther. 1987 Jan; 41(1):118-23. PMID: 3802701.
      View in: PubMed
    110. Thadani U. The effectiveness of transcutaneous nitrate preparations for angina pectoris. Int J Cardiol. 1987 Jan; 14(1):9-14. PMID: 3100461.
      View in: PubMed
    111. Thadani U, Hamilton SF, Olson E, Anderson J, Voyles W, Prasad R, Teague SM. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Ann Intern Med. 1986 Oct; 105(4):485-92. PMID: 3092711.
      View in: PubMed
    112. Shapiro W, DiBianco R, Thadani U. Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris. Am J Cardiol. 1985 Mar 15; 55(7):36C-42C. PMID: 3919556.
      View in: PubMed
    113. Thadani U. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris. Z Kardiol. 1985; 74 Suppl 4:21-4. PMID: 4096067.
      View in: PubMed
    114. Thadani U. Assessment of "optimal" beta blockade in treating patients with angina pectoris. Acta Med Scand Suppl. 1985; 694:178-87. PMID: 2860773.
      View in: PubMed
    115. Thadani U. Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance. Herz. 1984 Jun; 9(3):123-36. PMID: 6430766.
      View in: PubMed
    116. Thadani U, Kellerman D. Interaction of indomethacin and nitroglycerin on hemodynamics and exercise tolerance in patients with angina pectoris. Z Kardiol. 1983; 72 Suppl 3:35-9. PMID: 6421013.
      View in: PubMed
    117. Thadani U. Beta adrenergic blocking agents for exertional angina pectoris. Herz. 1982 Jun; 7(3):179-87. PMID: 6124493.
      View in: PubMed
    118. Thadani U, Fung HL, Darke AC, Parker JO. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy. Am J Cardiol. 1982 Feb 01; 49(2):411-9. PMID: 7058754.
      View in: PubMed
    119. Fung HL, McNiff EF, Ruggirello D, Darke A, Thadani U, Parker JO. Kinetics of isosorbide dinitrate and relationships to pharmacological effects. Br J Clin Pharmacol. 1981 Jun; 11(6):579-89. PMID: 7272174.
      View in: PubMed
    120. Olowoyeye JO, Thadani U, Parker JO. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily. Am J Cardiol. 1981 May; 47(5):1123-7. PMID: 7223659.
      View in: PubMed
    121. Thadani U, Fung HL, Darke AC, Parker JO. Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy. Circulation. 1980 Sep; 62(3):491-502. PMID: 7398008.
      View in: PubMed
    122. Thadani U, Parker JO. Propranolol in angina pectoris: comparison of therapy given two and four times daily. Am J Cardiol. 1980 Jul; 46(1):117-23. PMID: 7386384.
      View in: PubMed
    123. Thadani U, Lewis JR, Manyari D, Boroomand K, Cohen J, West RO, Parker JO. Are the clinical and hemodynamic events during exercise stress testing in invasive studies in patients with angina pectoris reproducible? Circulation. 1980 Apr; 61(4):744-50. PMID: 7357716.
      View in: PubMed
    124. Thadani U, Manyari D, Parker JO, Fung HL. Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate. Circulation. 1980 Mar; 61(3):526-35. PMID: 6766360.
      View in: PubMed
    125. Thadani U, Davidson C, Singleton W, Taylor SH. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris. Am J Med. 1980 Feb; 68(2):243-50. PMID: 6101934.
      View in: PubMed
    126. Thadani U, Chiong MA, Parker JO. Effects of low and high glucose in a glucose-insulin-potassium infusion on hemodynamics and exercise tolerance in patients with angina pectoris. Circulation. 1980 Feb; 61(2):266-76. PMID: 7351052.
      View in: PubMed
    127. Thadani U, Lewis JR, Mathew TM, West RO, Parker JO. Reproducibility of clinical and hemodynamic parameters during pacing stress testing in patients with angina pectoris. Circulation. 1979 Nov; 60(5):1036-44. PMID: 487537.
      View in: PubMed
    128. Thadani U, Lewis RJ, West RO, Chiong MA, Parker JO. Clinical, hemodynamic and metabolic responses during pacing in the supine and sitting postures in patients with angina pectoris. Am J Cardiol. 1979 Aug; 44(2):249-56. PMID: 463763.
      View in: PubMed
    129. Thadani U, Parker JO. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration. Am J Cardiol. 1979 Jul; 44(1):118-25. PMID: 377932.
      View in: PubMed
    130. Thadani U, Davidson C, Singleton W, Taylor SH. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. N Engl J Med. 1979 Apr 05; 300(14):750-5. PMID: 581782.
      View in: PubMed
    131. Thadani U, Parker JO. Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy. Circulation. 1979 Mar; 59(3):571-9. PMID: 761338.
      View in: PubMed
    132. Thadani U, Chiong MA, Parker JO. Effects of glucose-insulin-potassium infusion on the angina response during treadmill exercise. Cardiology. 1979; 64(6):333-49. PMID: 389419.
      View in: PubMed
    133. Thadani U, Parker JO. Influence of glyceryl trinitrate during supine and upright exercise in patients with angina pectoris. Br Heart J. 1978 Nov; 40(11):1229-36. PMID: 102331.
      View in: PubMed
    134. Thadani U, Parker JO. Hemodynamics at rest and during supine and sitting bicycle exercise in normal subjects. Am J Cardiol. 1978 Jan; 41(1):52-9. PMID: 623005.
      View in: PubMed
    135. Goldstraw PW, Taylor SH, Thadani U, Watt SJ. Slow release oxprenolol in angina pectoris [proceedings]. Br J Clin Pharmacol. 1977 Jun; 4(3):387P. PMID: 332219.
      View in: PubMed
    136. Thadani U, West RO, Mathew TM, Parker JO. Hemodynamics at rest and during supine and sitting bicycle exercise in patients with coronary artery disease. Am J Cardiol. 1977 May 26; 39(6):776-83. PMID: 871106.
      View in: PubMed
    137. Sharma B, Raphael MJ, Thadani U, Taylor SH, Steiner RE, Goodwin JF. Proceedings: Left ventricular pressure-volume changes during exercise-induced pain in patients with angina pectoris. Br Heart J. 1974 Oct; 36(10):1038. PMID: 4433445.
      View in: PubMed
    138. Sharma B, Thadani U, Taylor SH. Cardiovascular effects of weight reduction in obese patients with angina pectoris. Br Heart J. 1974 Sep; 36(9):854-8. PMID: 4425600.
      View in: PubMed
    139. Thadani U, Sharma B, Meeran MK, Majid PA, Whitaker W, Taylor SH. Comparison of adrenergic beta-receptor antagonists in angina pectoris. Br Med J. 1973 Jan 20; 1(5846):138-42. PMID: 4145234.
      View in: PubMed
    140. Chopra MP, Thadani U, Portal RW, Aber CP. Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial. Br Med J. 1971 Sep 18; 3(5776):668-70. PMID: 4936439.
      View in: PubMed
    Thadani's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description